Children with Down’s syndrome have a 150-fold increased risk of developing leukaemia than those without the condition. Now, ...

A core task in single-cell data analysis is recovering the latent dimensions encoding the genetic and epigenetic landscapes inhabited by cell types and lineages. However, consensus is lacking for ...

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can ...

Discovery could lead to development of new drugs to treat inflammation, coronary artery disease, cancer, more Steven Mansoor, ...

Small interfering RNA (siRNA) molecules hold immense potential for treating diseases by silencing specific genes. Encapsulated in lipid nanoparticles (LNPs), siRNA can be delivered efficiently to ...

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

Scientists have discovered that a molecule called kalata B1, found in violets, can significantly enhance the effectiveness of the chemotherapy drug Temozolomide (TMZ) in treating glioblastoma.

The sequencing of the human genome at the turn of the 21st century was heralded as a monumental scientific achievement ...

Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today announced the presentation of preclinical data demonstrating the ...

Optimizing electrical conductivity in next-generation batteries depends on carefully controlling process variables, such as ...

Veolia, world leader in hazardous waste management, has supported Imperial College London to successfully decommission the ...

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, ...